Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail emerging and cutting-edge vaccines that are now awaiting regulatory approval ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 ... represents an important ...

The company has also filed for FDA approval of its flu+Covid combination vaccine, mRNA-1083. If approved, it will be the first in the US to offer protection against flu and Covid-19 in a single shot.

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request ...

The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...

More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

Kennedy Jr., and that the deputy commissioner at the FDA intervened in the ... which is contingent on the approval. But Sanofi can still go ahead with the vaccine rollout on the basis of the ...

Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine.

But with FDA action, it would be the third vaccine against COVID-19 to receive full FDA approval. Full approval would make the vaccine available beyond an emergency declaration and could provide ...

The delay dovetails with moves by Republican lawmakers in at least 7 states to ban or limit mRNA vaccines. HealthDay News — The US Food and Drug Administration (FDA) has delayed the full ...